Literature DB >> 7069681

Madreporique stemmed total hip replacement: five years' clinical experience.

G A Lord.   

Abstract

Between February 1975 and December 1980, 1214 total hip arthroplasties were performed with a new type of rough surface implant. The results, pitfalls and complications are presented with special reference to the first 173 cases which have had a complete clinical and radiological follow up for at least five years. The indications for operations in both primary and revision arthroplasties are defined.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069681      PMCID: PMC1437586          DOI: 10.1177/014107688207500305

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  5 in total

1.  [The fixation of madreporic total hip prosthesis; an experimental study (author's transl)].

Authors:  G Lord; J H Marotte; J P Blanchard; J L Guillamon; M Gory
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1978-09

2.  [Biological fixation of total hip arthroplasty without cement. Initial evaluation of 200 madreporic prostheses].

Authors:  G Lord; J H Marotte; J P Blanchard; J L Guillamon; M Gory
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1978

3.  [A study of the potential corrosion of the madreporic prostheses compared with plane surface prostheses (author's transl)].

Authors:  G Lord; M Bancel; P Bancel
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1979-09

4.  [The stress in femoral prosthesis: a study of the importance of the diaphyseal support and horizontal setting (author's transl)].

Authors:  G Lord; J H Marotte; J P Blanchard; J L Guillamon; P Bancel
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1980 Apr-May

5.  Proximal strain distribution in the loaded femur. An in vitro comparison of the distributions in the intact femur and after insertion of different hip-replacement femoral components.

Authors:  I Oh; W H Harris
Journal:  J Bone Joint Surg Am       Date:  1978-01       Impact factor: 5.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.